Constellation Brands Inc. Common Stock vs Veeva Systems — how do they compare? Constellation Brands Inc. Common Stock trades at $129 (market cap $21.56B), while Veeva Systems trades at $298.77 (market cap $48.14B). The key difference: Veeva Systems is far larger — about 2.2× Constellation Brands Inc. Common Stock's market cap, and Constellation Brands Inc. Common Stock pays a 3.23% dividend while Veeva Systems pays none. Which is the better fit depends on your goals.
| STZ | VEEV | |
|---|---|---|
Market Cap | $21.56B | $48.14B |
Volume | 1,626,934 | 1,239,885 |
Sector | Consumer Staples | Technology |
52-Week High | $166.68 | $301.63 |
52-Week Low | $112.77 | $151.43 |
Enterprise Value | $31.78B | $41.05B |
Dividend Yield | 3.23% | — |
Typical Hold Time | — | 6 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Veeva Systems (VEEV) trades at $301.63, up 1.95% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 74.96% gross margins and consistent earnings beats, while expanding partnerships with IQVIA and Servier enhance growth prospects. Recent news highlights AI innovations and increasing adoption among biotech firms, supporting positive sentiment.
Outlook remains favorable with analyst consensus at Buy (67% rating) and $290.50 price target, though valuation multiples appear elevated. Key risks include market saturation concerns and potential volatility from RSI overbought signals. The stock's proximity to 52-week highs suggests continued investor confidence in Veeva's life sciences software leadership.
Trailing returns across standard periods
Latest headlines on both assets
Constellation Brands, Inc. is a US producer and marketer of beer, wine, and spirits, known for importing Mexican beer brands Corona and Modelo alongside a portfolio of wine and craft spirits labels.
Read more on STZ →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →